Chemical/biological hybrid process that deconstructs mixed postconsumer plastics via pyrolysis or hydrolysis and feeds the resulting small molecules to microorganisms to produce value-added biochemicals, offering a circular economy alternative to traditional recycling.
This solution addresses one of the most pressing challenges in plastic waste management by combining thermal deconstruction with microbial bioconversion. Postconsumer plastics such as polyesters, polypropylene, and nylon 6,6 are broken down through pyrolysis or hydrolysis into smaller, bioavailable molecules. These plastic-derived molecules are then fed to microorganisms that convert them into value-added biochemicals, including fatty acids. The hybrid approach overcomes the key limitation of microbial plastic metabolism, which is the low bioavailability of intact polymer chains, and provides a circular pathway for transforming waste streams into useful products.
The approach has been validated with multiple polymer types and specific microbial strains, with published results demonstrating fatty acid production from thermally depolymerized polypropylene. Current work is expanding to additional plastics such as polystyrene and to mixed-feedstock streams that reflect real-world postconsumer waste compositions. The technology is positioned at an early-to-mid stage of development, with ongoing validation of new feedstocks and microbial hosts to broaden applicability and move toward scaled demonstration.
Georgia State University is a comprehensive public research university in downtown Atlanta, serving a large and diverse student body with a rapidly growing research enterprise. An urban innovation district and co-located collaboration spaces link faculty and students with corporate partners for prototyping, user testing, and joint problem-solving. Shared core laboratories and campus computing resources support industry-sponsored work, while proximity to Fortune 500 headquarters, major hospital systems, and the CDC enables quick access to real-world testbeds. Research is backed by competitive federal funding from agencies such as NIH, NSF, and DoD. A dedicated technology transfer office streamlines IP, licensing, and startup formation to speed commercialization.